drugset / Trial / NCT03413020
Tailored Therapy for Helicobacter Pylori Rescue Treatment
NaSingle-groupOpen-labelTreatment
Summary
With increasing antibiotic resistance and unsatisfactory results of empiric eradication regimens, tailored therapy may be the best choice to achieve high efficacy for rescue treatment. This study aimed to evaluate the eradication rates, safety, and compliance of antimicrobial susceptibility-based tailored therapy for rescue treatment in patients with Helicobacter pylori infection.
Timeline
- Start
- 2018-01-03
- Primary completion
- 2018-07-31
- Completion
- 2018-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Bismuth Potassium Citrate | Unknown | 220 mg | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Esomeprazole | Small molecule | 20 mg | — |
| Subject | Levofloxacin | Small molecule | 500 mg | — |
| Subject | Metronidazole | Small molecule | 400 mg | — |